Researchers have just released Meditron, the world's best performing open source Large Language Model tailored to the medical field designed to help guide clinical decision-making.

Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor's antigenic makeup. The new results may pave the way to first-in-kind clinical applications.

Biological computing machines, such as micro and nano-implants that can collect important information inside the human body, are transforming medicine. Yet, networking them for communication has proven challenging. Now, a global team, including researchers, has developed a protocol that enables a molecular network with multiple transmitters.

A new material developed at EPFL could change how we make cement forever - and cut 500 million tons of emissions by 2030.

A groundbreaking study reveals how Mycobacterium tuberculosis forms resilient cords within host cells, opening the way for a deeper understanding and innovative treatment of tuberculosis.

Global warming is causing extensive changes to peatland vegetation in Europe and Western Siberia, with consequences for soil composition and the peatlands' ability to sequester carbon. An EPFL-led study has examined the mechanisms behind these complex processes.

EPFL spin-off Qaptis has developed a system that can cut freight trucks' carbon emissions by up to 90%. The company just installed a prototype of its technology at a freight carrier based in Tolochenaz in order to conduct pilot tests locally.

Scientists have crafted a biological system that mimics an electronic bandpass filter, a novel sensor that could revolutionize self-regulated biological mechanisms in synthetic biology.